Acute respiratory diseases are common in pediatric patients scheduled for general anesthesia, and can cause perioperative problems up to 6 weeks after the acute respiratory infection. In the present double-blind, randomized study the effect of lidocain gel for laryngeal mask lubrification on the rate of perioperative respiratory adverse events is studied in pediatric patients with a recent history of respiratory infection and in patients without a history of respiratory infection. MedDRA vers
Conditions
Interventions
Trade Name: Xylocain Gel 2 %
Product Name: Xylocain 2 % Gel
Pharmaceutical Form: Gel
INN or Proposed INN: Lidocain
CAS Number: 6108050
Current Sponsor code: no sponsor
Other descriptive name: ---
Conc
Sponsors
Medical University of Vienna, Department of Anesthesiology
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: patients: male, age 1 - 6, scheduled for circumcision, otherwise healthy Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: all patients with indications for endotracheal intubation, patients with a history of allergies against local anesthetics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Study the effect of topical anesthesia with lidocain gel for laryngeal mask lubrification on perioperative respiratory adverse events in pediatric patients undergoing general anesthesia with or without a recent history of acutes respiratory disease ;Secondary Objective: none;Primary end point(s): Sum of perioperative adverse respiratory events (Tait et al., Anesthesiology 2001) | — |
Countries
Austria
Outcome results
None listed